CAESAR’s QSAR models for REACH

CAESAR was an EC funded project (Project no. 022674 - SSPI), which was specifically dedicated to develop QSAR models for the REACH legislation.

Five endpoints with high relevance for REACH have been addressed within CAESAR:

  • bioconcentration factor
  • skin sensitization
  • carcinogenicity
  • mutagenicity
  • developmental toxicity

CAESAR models have been assessed according to the OECD principles for the validation of QSAR. For the model validity we used a wide series of statistical checks. We also used external tests, to verify that the models performs correctly on new compounds.

CAESAR models are now freely available in the SOFTWARE section of this website.